Boston Scientific Corp
(MIL:1BSX)
€
85.5
0 (0%)
Market Cap: 126.98 Bil
Enterprise Value: 135.61 Bil
PE Ratio: 74.26
PB Ratio: 6.39
GF Score: 56/100 Boston Scientific Corp at Stifel Healthcare Conference (Virtual) Transcript
Nov 15, 2021 / 01:00PM GMT
Frederick Allen Wise
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst
Good morning, everybody, and welcome to the very first meeting of the Stifel Annual Healthcare Conference. Thank you for joining us. I'm particularly pleased to be starting off today's meeting and the conference, in general, with Boston Scientific.
I'd like to very much welcome Dan Brennan, Executive Vice President and Chief Financial Officer; as well as his colleague Lauren Tengler, VP of Investor Relations. Welcome. Good morning. Thanks to you both for being here.
Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO
Thanks, Rick. Always a pleasure. Thanks for the invitation.
Frederick Allen Wise;Daniel J.
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst
Thank you. And, Dan, I know that you are going to start us off this morning with a few high-level words. Thank you. Over to you.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot